Joint Formulary & PAD

Botulinum toxin type A - Gastroparesis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important

RSCH - endoscopy only.

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Gastroparesis
Group Name :
Keywords :
gastric stasis
Brand Names Include :
Botox, Xeomin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Drugs

Below are listed other drugs that are used to treat Gastroparesis.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.